Inventor · disambiguated record
Kevin Gagnon
Also filed as: GAGNON KEVIN · GAGNON KEVIN J · GAGNON KEVIN JAMES
7 granted patents·6 pending applications·21 citations·filing 2019–2024
81Inventor score
Files withVERTEX PHARMA13
Top patents by PatentIndex Score
13 records- 0196US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 0291US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 0391US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 0491US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 0589US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 0685US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 0779US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 0878US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0968US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1061US2025340568A1Solid forms of a macrocyclic compounds as cftr modulators and their preparationVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1161US2025320226A1Methods of preparing and crystalline forms of (6a,12a)-17-amino-12-methyl-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(18),2,4,14,16-pentaen-6-olVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1247US2023119114A1Solid forms of apol1 inhibitors and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1345US2021246121A1Solid forms of apol1 inhibitor and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Gagnon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →